Advances in targeted therapy and cocktail targeted therapy for chronic myeloid leukemia
10.3760/cma.j.issn.1009-9921.2016.10.018
- VernacularTitle:慢性粒细胞白血病靶向治疗和靶向鸡尾酒疗法研究进展
- Author:
Yang ZHANG
;
Xue CHEN
;
Hongxing LIU
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,chronic;
Tyrosine kinase inhibitors;
Target therapy
- From:
Journal of Leukemia & Lymphoma
2016;25(10):632-636
- CountryChina
- Language:Chinese
-
Abstract:
Although tyrosine kinase inhibitors (TKI) have profoundly improved prognosis of patients with chronic myeloid leukemia (CML), it still can not cure CML with high relapse rate when TKI is used alone. Except for effective development of TKI and precise application of the existing TKI,the exploitation of new therapy target, research on treatment for leukemia stem cells and cocktail targeted therapies also provide further inspiration for improving treatment and curing CML. This article will introduce the advances of therapy in CML.
